Cited by

• Characterization of Isolates from an outbreak of multidrug-resistant, Shiga toxin-producing Escherichia coli O145 in the United States.

  Folster JP, Pecic G, Taylor E, Whichard J. Folster JP, et al. Antimicrob Agents Chemother. 2011 Dec;55(12):5955-6. doi: 10.1128/AAC.05545-11. Epub 2011 Sep 19. Antimicrob Agents Chemother. 2011. PMID: 21930875 Free PMC article. No abstract available.
• O157:H7 and O104:H4 Vero/Shiga toxin-producing Escherichia coli outbreaks: respective role of cattle and humans.

  Piérard D, De Greve H, Haesebrouck F, Mainil J. Piérard D, et al. Vet Res. 2012 Feb 13;43(1):13. doi: 10.1186/1297-9716-43-13. Vet Res. 2012. PMID: 22330148 Free PMC article. Review.
• Development of a rapid microarray-based DNA subtyping assay for the alleles of Shiga toxins 1 and 2 of Escherichia coli.

  Geue L, Stieber B, Monecke S, Engelmann I, Gunzer F, Slickers P, Braun SD, Ehricht R. Geue L, et al. J Clin Microbiol. 2014 Aug;52(8):2898-904. doi: 10.1128/JCM.01048-14. Epub 2014 Jun 4. J Clin Microbiol. 2014. PMID: 24899022 Free PMC article.
• Virulence gene profiles and phylogeny of Shiga toxin-positive Escherichia coli strains isolated from FDA regulated foods during 2010-2017.

  González-Escalona N, Kase JA. González-Escalona N, et al. PLoS One. 2019 Apr 1;14(4):e0214620. doi: 10.1371/journal.pone.0214620. eCollection 2019. PLoS One. 2019. PMID: 30934002 Free PMC article.
• Synthesis and Antibacterial Activity of Ionic Liquids and Organic Salts Based on Penicillin G and Amoxicillin hydrolysate Derivatives against Resistant Bacteria.

  Ferraz R, Silva D, Dias AR, Dias V, Santos MM, Pinheiro L, Prudêncio C, Noronha JP, Petrovski Ž, Branco LC. Ferraz R, et al. Pharmaceutics. 2020 Mar 2;12(3):221. doi: 10.3390/pharmaceutics12030221. Pharmaceutics. 2020. PMID: 32131540 Free PMC article.